NexImmune Statistics
Share Statistics
NexImmune has 1.39M shares outstanding. The number of shares has increased by 17.86% in one year.
| Shares Outstanding | 1.39M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | 0% |
| Owned by Institutions (%) | n/a |
| Shares Floating | 1.18M |
| Failed to Deliver (FTD) Shares | 105 |
| FTD / Avg. Volume | 1.57% |
Short Selling Information
The latest short interest is 15.99K, so 1.15% of the outstanding shares have been sold short.
| Short Interest | 15.99K |
| Short % of Shares Out | 1.15% |
| Short % of Float | 1.36% |
| Short Ratio (days to cover) | 2.26 |
Valuation Ratios
The PE ratio is -0.07 and the forward PE ratio is -0.06.
| PE Ratio | -0.07 |
| Forward PE | -0.06 |
| PS Ratio | 0 |
| Forward PS | null |
| PB Ratio | 0.66 |
| P/FCF Ratio | -0.07 |
| PEG Ratio | n/a |
Enterprise Valuation
Currently the Enterprise Value (EV) is not available for NexImmune Inc..
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.06, with a Debt / Equity ratio of 0.
| Current Ratio | 1.06 |
| Quick Ratio | 1.06 |
| Debt / Equity | 0 |
| Total Debt / Capitalization | 0 |
| Cash Flow / Debt | 0 |
| Interest Coverage | 0 |
Financial Efficiency
Return on equity (ROE) is -9.22% and return on capital (ROIC) is -815.77%.
| Return on Equity (ROE) | -9.22% |
| Return on Assets (ROA) | -3.76% |
| Return on Capital (ROIC) | -815.77% |
| Revenue Per Employee | 0 |
| Profits Per Employee | -5.39M |
| Employee Count | 6 |
| Asset Turnover | 0 |
| Inventory Turnover | 0 |
Taxes
| Income Tax | -2 |
| Effective Tax Rate | 0 |
Stock Price Statistics
The stock price has increased by -98.73% in the last 52 weeks. The beta is 1.69, so NexImmune 's price volatility has been higher than the market average.
| Beta | 1.69 |
| 52-Week Price Change | -98.73% |
| 50-Day Moving Average | 0.25 |
| 200-Day Moving Average | 1.68 |
| Relative Strength Index (RSI) | 37.68 |
| Average Volume (20 Days) | 6.67K |
Income Statement
| Revenue | n/a |
| Gross Profit | -1.02M |
| Operating Income | -29.19M |
| Net Income | -32.34M |
| EBITDA | -28.17M |
| EBIT | n/a |
| Earnings Per Share (EPS) | -30.82 |
Balance Sheet
The company has 3.20M in cash and 68.81K in debt, giving a net cash position of 3.13M.
| Cash & Cash Equivalents | 3.20M |
| Total Debt | 68.81K |
| Net Cash | 3.13M |
| Retained Earnings | -222.59M |
| Total Assets | 5.86M |
| Working Capital | -1.61M |
Cash Flow
In the last 12 months, operating cash flow was -31.43M and capital expenditures -48.72K, giving a free cash flow of -31.48M.
| Operating Cash Flow | -31.43M |
| Capital Expenditures | -48.72K |
| Free Cash Flow | -31.48M |
| FCF Per Share | -30 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
NEXI does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | -20546.67% |
| FCF Yield | -15178.92% |
Analyst Forecast
Currently there are no analyst rating for NEXI.
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
Stock Splits
The last stock split was on Oct 19, 2023. It was a backward split with a ratio of 1:25.
| Last Split Date | Oct 19, 2023 |
| Split Type | backward |
| Split Ratio | 1:25 |
Scores
| Altman Z-Score | -64.01 |
| Piotroski F-Score | 2 |